Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

被引：0

作者：

Younossi, Zobair ^{[1
,2
]}

Yilmaz, Yusuf ^{[1
,3
]}

Yu, Ming-Lung ^{[1
,4
,5
]}

Isakov, Vasily ^{[1
,6
]}

Fernandez, Marlen Ivon Castellanos ^{[1
,7
]}

Wong, Vincent Wai-Sun ^{[1
,8
]}

Eguchi, Yuichiro ^{[1
,9
]}

Romero-Gomez, Manuel ^{[1
,10
]}

Mendez-Sanchez, Nahum ^{[1
,11
]}

Duseja, Ajay Kumar ^{[1
,12
]}

Keklikkiran, Caglayan ^{[1
,13
]}

George, Jacob ^{[1
,14
]}

Bugianesi, Elisabetta ^{[1
,15
]}

Singal, Ashwani K. ^{[1
,16
]}

Hamid, Saeed Sadiq ^{[1
,17
]}

Alswat, Khalid A. ^{[1
,18
]}

Chan, Wah-Kheong ^{[1
,19
]}

Fan, Jiangao ^{[1
,20
]}

Papatheodoridis, George ^{[1
,21
]}

Gordon, Stuart C. ^{[1
]}

El-Kassas, Mohamed ^{[1
,23
]}

Roberts, Stuart ^{[1
,22
,24
]}

Lam, Brian ^{[1
,25
]}

Racila, Andrei ^{[26
]}

Henry, Linda ^{[1
]}

Alqahtani, Saleh ^{[1
,27
,28
]}

Stepanova, Maria ^{[1
,29
]}

机构：

[1] Global NASH Council, Washington, DC USA

[2] Beatty Liver & Obes Res Program, Falls Church, VA USA

[3] Marmara Univ, Inst Gastroenterol, Liver Res Unit, Istanbul, Turkiye

[4] Natl Sun Yat Sen Univ, Kaohsiung Med Univ Hosp, Sch Med & Doctoral Program Clin & Expt Med, Hepatobiliary Div,Dept Internal Med,Coll Med, Kaohsiung, Taiwan

[5] Natl Sun Yat Sen Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div,Dept Internal Med, Ctr Excellence Metab Associated Fatty Liver Dis, Kaohsiung, Taiwan

[6] Inst Nutr, Chief Gastroenterol & Hepatol, Moscow, Russia

[7] Univ Med Sci Havana, Inst Gastroenterol, Havana, Cuba

[8] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[9] Locomed Gen Inst, Locomed Med Cooperat, Saga, Japan

[10] Virgen Rocio Univ Hosp, Inst Biomed, Digest Dis Dept, Seville, Spain

[11] Univ Nacl Autonoma Mexico, Liver Res Unit, Med Clin & Fdn, Mexico City, DF, Mexico

[12] Postgrad Inst Med Educ & Res, Deptt Hepatol, Chandigarh, India

[13] Recap Tayyip Erdogan Univ, Sch Med, Dept Gastroenterol, Rize, Turkiye

[14] Westmead Univ Sydney, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW, Australia

[15] Univ Torino, Dept Med Sci, Div Gastroenterol, Turin, Italy

[16] Univ Louisville, Sch Med, Louisville, KY USA

[17] Aga Khan Univ, Med Dept, Karachi, Pakistan

[18] King Saud Univ, Dept Med, Coll Med, Liver Dis Res Ctr, Riyadh, Saudi Arabia

[19] Univ Malaya, Dept Med, Gastroenterol & Hepatol Unit, Fac Med, Kuala Lumpur, Malaysia

[20] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China

[21] Natl & Kapodistrian Univ Athens, Athens, Greece

[22] Henry Ford Hosp Syst, Dept Gastroenterol & Hepatol, Detroit, MI USA

[23] Helwan Univ, Endemic Med Dept, Fac Med, Cairo, Egypt

[24] The Alfred, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia

[25] Beatty Liver & Obes Res Program, Falls Church, VA USA

[26] Global Nash Council, Washington, DC USA

[27] Johns Hopkins Univ, Organ Transplant Ctr Excellence, Baltimore, MD USA

[28] King Faisal Specialist Hosp & Res Ctr, Div Gastroenterol & Hepatol, Riyadh, Saudi Arabia

[29] Ctr Outcomes Res Liver Dis, Washington, DC USA

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-438

引用

页码：S643 / S644

页数：2

共 50 条

[1] Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
Barbera, Aurora
White, Trenton M.
Arora, Anish K.
Henry, Linda
Lazarus, Jeffrey V.
Younossi, Zobair M.
SEMINARS IN LIVER DISEASE, 2024,
[2] Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Hashida, Ryuki
Kawaguchi, Takumi
Nakano, Dan
Tsutsumi, Tsubasa
Kawaguchi, Machiko
Takahashi, Hirokazu
Tajima, Hiroshi
Matsuse, Hiroo
Golabi, Pegah
Gerber, Lynn H.
Younossi, Zobair M.
Hiraoka, Koji
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (02) : 190 - 197
[3] A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease
Sapmaz, Aybuke
Paik, Annette
Henry, Linda
Younossi, Zobair M.
METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
[4] A prospective assessment of disease progression impact on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease
O'Connor, Ian P.
Neuschwander-Tetri, Brent A.
Newsome, Philip N.
Mospan, Andrea
Morris, Heather
Schoen, Cheryl
Barritt, A. Sidney
Sanyal, Arun J.
JOURNAL OF HEPATOLOGY, 2024, 80 : S472 - S473
[5] A PROSPECTIVE ASSESSMENT OF THE IMPACT OF DECOMPENSATION OF CIRRHOSIS ON PATIENT-REPORTED OUTCOMES IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
O'Connor, Ian
Mospan, Andrea
Schoen, Cheryl
Barritt, Alfred
Sanyal, Arun
HEPATOLOGY, 2024, 80 : S843 - S844
[6] Evolutionary aspects of metabolic dysfunction-associated steatotic liver disease (MASLD)
Geier, Andreas
Schiffels, Stephan
Krawczyk, Marcin
GASTROENTEROLOGIE, 2025,
[7] Exercise in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is Associated With Better Metabolic Profile and Higher Scores for Patient Reported Outcomes (PROs): Data From the Global NASH/MASH Registry
Alqahtani, Saleh A.
Stepanova, Maria M.
Alahamed, Reem
Henry, Linda
Racila, Andrei
Nader, Fatema
Eguchi, Yuichiro
Yilmaz, Yusuf
Mohammed, Manal
Younossi, Zobair
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1289 - S1289
[8] CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH CIRRHOSIS DUE TO METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN SWEDEN
Shang, Ying
Zhang, Xiao
Fernandes, Gail
Melaragno, Matthew
Engel, Samuel
Vessby, Johan
Ekstedt, Mattias
Hagstrom, Hannes
HEPATOLOGY, 2024, 80 : S821 - S822
[9] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Liu, Huan
Yerevanian, Armen
Westerhoff, Maria
Hastings, Margaret H.
Guerra, Justin Ralph Baldovino
Zhao, Meng
Svensson, Katrin J.
Cai, Bishuang
Soukas, Alexander A.
Rosenzweig, Anthony
DIABETES, 2024, 73 (02) : 260 - 279
[10] Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Iturbe-Rey, Santiago
Maccali, Claudia
Arrese, Marco
Aspichueta, Patricia
Oliveira, Claudia P.
Castro, Rui E.
Lapitz, Ainhoa
Izquierdo-Sanchez, Laura
Bujanda, Luis
Perugorria, Maria J.
Banales, Jesus M.
Rodrigues, Pedro M.
ATHEROSCLEROSIS, 2025, 400

← 1 2 3 4 5 →